Grants per year
Personal profile
Professional Affiliations
St. Joseph Orange |
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
Cancer Center Support Grant
Atiba, J. O. (CoPI), Burger, R. A. (CoPI), Cahalan, M. D. (CoPI), Fruehauf, J. P. (CoPI), Glabe, C. (CoPI), Henschen-edman, A. H. (CoPI), Krolewski, J. J. (CoPI), Lander, A. (CoPI), Lin, F. (CoPI), McLaren, C. E. (CoPI), Mevskens, F. (CoPI), Meyskens, F. L. (CoPI), Moyzis, R. K. (CoPI), Nalcioglu, O. (CoPI), Sandmeyer, S. (CoPI), Schell, M. J. (CoPI), Villarreal, L. P. (CoPI), Van Etten, R. R. A. (PI), Ganesan, A. A. K. (CoPI), Hamkalo, B. B. A. (CoPI), Blumberg, B. (CoPI), Hui, C. C. N. (CoPI), Nelson, E. E. L. (CoPI), Edwards, R. A. (CoPI), Fruman, D. A. (CoPI), Gershon, P. D. (CoPI), Gillen, D. L. (CoPI), Greenfield, S. (CoPI), Gulsen, G. (CoPI), Hsiang, D. (CoPI), Hughes, C. C. W. (CoPI), Milam, J. J. E. (CoPI), Lowengrub, J. J. (CoPI), Carmichael, J. J. (CoPI), Macgregor, G. R. (CoPI), Marsh, L. J. (CoPI), Kohler, M. F. (CoPI), Waterman, M. M. L. (CoPI), Funes, M. M. (CoPI), Poulos, T. L. (CoPI), Niece, R. R. (CoPI), Su, M.-Y. L. (CoPI), Lee, S. S. (CoPI), O'brien, S. S. M. (CoPI), Tanjasiri, S. S. P. (CoPI), Tewari, K. (CoPI), Kurosaki, T. T. (CoPI) & Wenzel, L. (CoPI)
08/15/94 → 01/31/25
Project: Research
-
-
Novel biologic markers of treatment resistance in locally advanced cervical carci
Tewari, K. (PI) & Fruehauf, J. P. (CoPI)
01/1/11 → 12/31/15
Project: Research
-
A review of racial disparities in ovarian cancer and clinical trials
Ali, M. & Tewari, K. S., Feb 1 2024, In: Current Opinion in Obstetrics and Gynecology. 36, 1, p. 23-27 5 p.Research output: Contribution to journal › Review article › peer-review
-
A systematic review of stage IVA cervical cancer treatment: Challenges in the management of an understudied group
Hunsberger, K. S., Treiman, S., Monk, B. J., Tewari, K. S., Taunk, N. K. & Chase, D. M., Aug 2024, In: Gynecologic Oncology. 187, p. 120-127 8 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
Atezolizumab plus bevacizumab and chemotherapy for metastatic, persistent, or recurrent cervical cancer (BEATcc): a randomised, open-label, phase 3 trial
ENGOT-Cx10–GEICO 68-C–JGOG1084–GOG-3030 Investigators, Jan 6 2024, In: The Lancet. 403, 10421, p. 31-43 13 p.Research output: Contribution to journal › Article › peer-review
Open Access45 Scopus citations -
Biomarker guidance in selection among breakthrough treatment options in advanced and recurrent endometrial cancer
Chan, J. K., Tewari, K., Monk, B. J., Herzog, T. J., Coleman, R. L., Richardson, M. T., Kapp, D. S. & Francoeur, A. A., Aug 2024, In: Gynecologic Oncology. 187, p. 249-252 4 p.Research output: Contribution to journal › Editorial
-
Cemiplimab monotherapy in Japanese patients with recurrent or metastatic cervical cancer
Hasegawa, K., Takahashi, S., Ushijima, K., Okadome, M., Yonemori, K., Yokota, H., Vergote, I., Monk, B. J., Tewari, K. S., Fujiwara, K., Li, J., Jamil, S., Paccaly, A., Takehara, K., Usami, T., Aoki, Y., Suzuki, N., Kobayashi, Y., Yoshida, Y. & Watari, H. & 5 others, , Sep 2024, In: Cancer Medicine. 13, 18, e70236.Research output: Contribution to journal › Article › peer-review
Open Access